Successful use of bortezomib in a patient with systemic lupus erythematosus and multiple myeloma

Annals of the Rheumatic Diseases

Volumn 70, Issue 7, 2011, Pages 1344-1345

  Fröhlich, Karen ^a   Holle, Julia U ^a   Aries, Peer M ^b   Gross, Wolfgang L ^a   Moosig, Frank ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Rheumatologie im Struenseehaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BORTEZOMIB; CELL NUCLEUS ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; EXTRACTABLE NUCLEAR ANTIGEN; IMMUNOGLOBULIN G; METHOTREXATE; PREDNISOLONE; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AUTOIMMUNE THROMBOCYTOPENIA; CASE REPORT; COOMBS TEST; DRUG DOSE REDUCTION; DRUG TOLERABILITY; EUROPEAN CONSENSUS LUPUS ACTIVITY MEASUREMENT; FEMALE; FOLLOW UP; HAIR LOSS; HEMOLYTIC ANEMIA; HUMAN; LETTER; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; POLYARTHRITIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BORONIC ACIDS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; MULTIPLE MYELOMA; PROTEASE INHIBITORS; PYRAZINES; TREATMENT OUTCOME;

EID: 79957653362     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.133256     Document Type: Letter

References (3)

1. Raab MS, Podar K, Breitkreutz I, et al. Multiple myeloma. Lancet 2009;374:324-39.
2. Neubert K, Meister S, Moser K, et al. The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis. Nat Med 2008;14:748-55. (Pubitemid 351951516)
3. Argyriou AA, Iconomou G, Kalofonos HP. Bortezomib-induced peripheral neuropathy in multiple myeloma: a comprehensive review of the literature. Blood 2008;112:1593-9.